Nick van Es, MD PhD

MD
Department of Vascular Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands

Nick van Es is specialized in Vascular Medicine at the Amsterdam University Medical Center. He defended his PhD-thesis “Cancer and thrombosis: improvements in strategies for prediction, diagnosis, and treatment” cum laude in 2017 under supervision of Saskia Middeldorp and Patrick Bossuyt. During his PhD trajectory, he completed a research traineeship at the The Ottawa Hospital supervised by Marc Carrier and Phil Wells. Trained as a Clinical Epidemiologist, his current research focuses on prediction, diagnosis, and treatment of venous thromboembolism, with a particular interest in cancer-associate thrombosis.

Presentation(s):

PB0441 - No pharmacological effect of the P-glycoprotein inhibitor tamoxifen on edoxaban plasma levels in patients with breast cancer: the PHIX-IT study
Sunday, July 10, 2022
6:30 PM – 7:30 PM
OC 31.1 - Performance of the 4-Level Pulmonary Embolism Clinical Probability Score (4PEPS) in the Diagnostic Management of Pulmonary Embolism
Monday, July 11, 2022
10:45 AM – 11:00 AM
OC 42.4 - Venous thromboembolism associated with oestrogen-containing contraceptives versus any hormonal risk factor: a comparison of recurrence rates
Monday, July 11, 2022
3:30 PM – 3:45 PM
PB0919 - Polygenic risk scores for prediction of cancer-associated venous thromboembolism: a UK Biobank analysis
Monday, July 11, 2022
6:30 PM – 7:30 PM
PB0920 - Performance of the Thrombogyn and Khorana scores for prediction of venous thromboembolism in ovarian cancer patients after major surgery
Monday, July 11, 2022
6:30 PM – 7:30 PM
OC 52.5 - Superficial venous thrombosis of the lower extremities during pregnancy and post partum: a Danish population-based cohort study
Tuesday, July 12, 2022
11:45 AM – 12:00 PM
LB 02.1 - Intermediate versus low-dose low-molecular-weight heparin in pregnant and postpartum women with a history of venous thromboembolism (Highlow Study)
Wednesday, July 13, 2022
10:15 AM – 10:30 AM